https://www.selleckchem.com/pr....oducts/Sunitinib-Mal
Outcomes related to patient comfort, particularly pain and analgesic requirement, were the most frequent domain for infants, children and adolescents. Clinical indicators, particularly cardiorespiratory or medication-related adverse events, were the most common outcomes for neonates and infants less then 60 weeks and were the second most frequent domain at all other ages. Neonates and infants less then 60 weeks of age were significantly under-represented in perioperative trials. Patient-centered outcomes, heath care ut